Literature DB >> 10939579

CB1 cannabinoid receptor induction in experimental stroke.

K L Jin1, X O Mao, P C Goldsmith, D A Greenberg.   

Abstract

Cannabinoids protect cortical neurons from ischemic injury by interacting with CB1 receptors. Because a variety of neuroprotective genes are induced in cerebral ischemia, we examined the effect of experimental stroke, produced by 20 minutes of middle cerebral artery occlusion in rats, on CB1 receptor expression. Western blotting and immunohistochemistry showed that CB1 expression on neurons was increased in the arterial boundary zone of the cortical mantle, beginning by 2 hours and persisting for 72 hours or more after ischemia These findings are consistent with a neuroprotective role for endogenous cannabinoid signaling pathways and with a potential therapeutic role in stroke for drugs that activate CB1 receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10939579

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  36 in total

1.  Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.

Authors:  D Fernández-López; J Faustino; N Derugin; M Wendland; I Lizasoain; M A Moro; Z S Vexler
Journal:  Neuroscience       Date:  2012-01-12       Impact factor: 3.590

Review 2.  The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.

Authors:  Roger G Pertwee
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

Review 3.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

Review 4.  In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.

Authors:  Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

5.  Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.

Authors:  Igor Grant; B Rael Cahn
Journal:  Clin Neurosci Res       Date:  2005

6.  Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report.

Authors:  Masayuki Nogi; David Fergusson; John Michael Chua Chiaco
Journal:  Hawaii J Med Public Health       Date:  2014-04

Review 7.  Cannabinoids in experimental stroke: a systematic review and meta-analysis.

Authors:  Timothy J England; William H Hind; Nadiah A Rasid; Saoirse E O'Sullivan
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

Review 8.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 9.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

10.  Possible Anandamide and Palmitoylethanolamide involvement in human stroke.

Authors:  Marcello Naccarato; Daniela Pizzuti; Stefania Petrosino; Marco Simonetto; Laura Ferigo; Fabio Chiodo Grandi; Gilberto Pizzolato; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.